High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.
Yong-Guang WeiCheng-Kun YangZhong-Liu WeiXi-Wen LiaoYong-Fei HeXin ZhouHua-Sheng HuangChen-Lu LanChuang-Ye HanTao PengPublished in: International journal of general medicine (2022)
In conclusions, HMGA1 is a potent prognostic biomarker and a sign of immune infiltration in HCC, which may be a potential immunotherapy target for HCC.
Keyphrases